Search Result "lapatinib derivatives."
Design, Synthesis and Biological Evaluation of Lapatinib Derivatives as HER1/HER2 Inhibitors
Journal: Letters in Drug Design & Discovery
Volume: 12 Issue: 7 Year: 2015 Page: 574-584
Author(s): Aifeng Lyu,Lei Fang,Shaohua Gou,Xia Liu
Lapatinib as a Chemotherapeutic Drug
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 3 Year: 2009 Page: 216-226
Author(s): Oluwakemi Obajimi
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 151-162
Author(s): Sylvia S. Gayle, Samuel L.M. Arnold, Ruth M. ORegan, Rita Nahta
Lessons from the Drug Discovery of Lapatinib, a Dual ErbB1/2 Tyrosine Kinase Inhibitor
Journal: Current Topics in Medicinal Chemistry
Volume: 6 Issue: 5 Year: 2006 Page: 435-460
Author(s): Karen E. Lackey
Synthetic Methodologies and SAR of Quinazoline Derivatives as PI3K Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 9 Year: 2023 Page: 1013-1047
Author(s): Ankit Kumar Singh
Targeted Anti-HER2 Cancer Therapy in Elderly Women Diagnosed with Breast Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 5 Year: 2014 Page: 639-645
Author(s): M.J. Molina-Garrido, C. Guillen-Ponce, A. Mora-Rufete
Anticancer Advances of Matrine and Its Derivatives
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 25 Year: 2015 Page: 3673-3680
Author(s): Jianping Yong,Xiaoyuan Wu,Canzhong Lu
Anticancer Potential of Thiazole Derivatives: A Retrospective Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 18 Issue: 8 Year: 2018 Page: 640-655
Author(s): Shweta Jain,Satyanarayan Pattnaik,Kamla Pathak,Sushant Kumar,Devender Pathak,Surendra Jain,Ankur Vaidya
Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens
Journal: Current Pharmacogenomics and Personalized Medicine
Volume: 7 Issue: 4 Year: 2009 Page: 263-274
Author(s): R. Nahta, S. Shabaya, T. Ozbay, D. L. Rowe
HER2 Targeted Monoclonal Antibodies and Tyrosine Kinase Inhibitors
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 4 Year: 2014
Author(s): Neil A. O`Brien,Alexandra Canonici,Karen Howe,Martina S.J. McDermott,Denis M. Collins,Brigid C. Browne,John Crown,Norma O`Donovan
Doi: 10.2174/978160859225114040007